Migraine Drug Ubrelvy May Stop Headaches Before They Start [Video]

Key Takeaways

An already approved drug can effectively prevent a coming migraine, trial results showUbrogepant (Ubrelvy) warded off migraine within a couple of hours in 73% of patientsThe drug blocks a small protein that plays a key role in pain transmission

THURSDAY, Aug. 29, 2024 (HealthDay News) — A migraine drug can help stop the devastating headaches in their tracks, allowing sufferers to go about their daily lives with little to no symptoms, a new clinical trial has found.

People who took ubrogepant (Ubrelvy) were 73% more likely to say they had no disability and were able to function normally within a couple of hours, compared to those who took a placebo, researchers reported Aug. 28 in the journal Neurology.

“Based on our findings, treatment with ubrogepant may allow people with migraine who experience early warning signs before a migraine occurs to quickly treat migraine attacks in their earliest stages and go about their daily lives with little discomfort and disruption,” …